The Newest Coronavirus Stock

With its drug candidate having demonstrated antiviral activity against the novel coronavirus in independent laboratory testing, this small-cap biotech joins the ever-growing list of coronavirus stocks. CLICK HERE.

read more

An Ideal Strategy For MedTech

While the deferral of elective medical/surgical procedures amid the coronavirus crisis has hit a number of MedTech names hard, there are also some fundamentally strong MedTech stocks with robust long-term […]

read more